The top five venture deals for 2024 raised a total of $358.5 million, nearly $125 million more than last year.

President-elect Donald Trump’s proposed tariffs on good from Canada, Mexico and China could raise costs, disrupt supply ...

J.P. Morgan has once again picked Boston Scientific (NYSE:BSX) and Intuitive Surgical (NASDAQ:ISRG) as its top large-cap ...

Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public ...

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

The integration of IoT and AI is not just a technological advancement—it’s a shift toward patient-centric care.

Last December, the FDA published its final guidance on predetermined change control plans, or PCCPs, with recommendations to ...

In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...

Medical technology Association of India (MTaI) is gearing up to host its flagship event, MedTekon 2025, on 30th January 2025 ...

China's National Medical Products Administration (NMPA) has approved the launch of Genesis Medtech’s iReach Omnia, a powered ...

Morgan Stanley (NYSE: MS) has upgraded its outlook for the European medical technology sector to "attractive," flagging ...

CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, ...